MedTrace Logo

Clinical Application of ctDNA in Early Screening of Breast Cancer

NCT03973034 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2019-06-04

No results posted yet for this study

Summary

The investigators aim to evaluate the possibility of clinical application of ctDNA detection in peripheral blood of normal people, benign breast disease patients and breast cancer patients, so as to act as the new techniques or indicators of early screening of breast cancer.

Conditions

Interventions

DIAGNOSTIC_TEST

Low depth whole genome sequencing

Low depth whole genome sequencing of the peripheral blood samples from different groups.

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2020-06-01
Completion
2021-06-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03973034 on ClinicalTrials.gov